FDA Panel Backs Pfizer COVID Booster For Some Groups
A U.S. Food and Drug Administration panel on Friday said it would only support emergency authorization for a third dose of the Pfizer and BioNTech COVID-19 vaccine for certain groups, dashing...To view the full article, register now.
Already a subscriber? Click here to view full article